Importantly, we find that USP21 is the most highly amplified DUB in hepatocellular carcinoma (HCC), a BRCA2-proficient tumor with poorly understood molecular pathways of carcinogenesis, a scarcity of druggable targets and a dismal therapeutic outcome26. Here, BRCA2 is linked to hepatocellular carcinoma.